LONG-TERM EFFICACY OF VEDOLIZUMAB THERAPY FOR CROHN’S DISEASE

(1) Digestive Health Center, Northwestern University Feinberg School Of Medicine, Chicago, United States

(2) Department Of Gastroenterology, University Hospital Gasthuisberg, Leuven, Belgium

(3) Inflammatory Bowel Disease Center, University Of Chicago Medicine, Chicago, United States

(4) Takeda Global Research & Development Centre (europe) Ltd., London, United Kingdom



This item was part of the New drugs in IBD session at UEG Week 2014

This item can be cited as: United European Gastroenterology Journal; 2014: 2 (Supplement 1)